+1 (704) 266-3234

Global Remote Patient Monitoring Solutions Market Outlook 2024: Global Opportunity And Demand Analysis, Market Forecast, 2016-2024

Published on: Aug 2017 | From USD $4750 | Published By: GOLDSTEIN RESEARCH | Number Of Pages: 250

Global Remote Patient Monitoring Solutions Market Outlook
Market Overview
Remote patient monitoring is an innovative solution in healthcare industry which can provide real time diagnosis and quality care to patients. In 2012, as per World Health organization (WHO), 82% of deaths worldwide are caused due cardiovascular diseases, diabetes and chronic respiratory diseases including asthma and chronic obstructive pulmonary disease (COPD). Remote patient monitoring technology is an innovative solution for congestive heart failure (CHF), diabetes and pulmonary diseases. Rising demand for home healthcare devices and equipment by geriatric population is positively impacting on the growth of global remote patient monitoring devices market. Rising popularity of mobile health (m-Health) apps is driving the demand for remote patient monitoring solutions market. Nearly 40% of market share of m-health is occupied by weight loss and management apps in 2016. Medscape, Ovulation Calendar & Fertility calculator, Urgent care-24/7 Medical Helps are some of the top medical apps available into the market.
Key market players are entering into strategic investment by collaboration and acquisition to expand their product portfolio and. In 2016, Qualcomm and Medtronic, a medical device company, collaborated to improve remote monitoring solutions for diabetic patients. Qualcomm is responsible for 47% reduction in heart failure readmissions attributed to remote patient monitoring. The collaboration of healthcare and IT companies aims to provide cost effective IT healthcare services such as remote patient monitoring. In the same year, Boston Scientific Corporation acquired Cosman Medical, Inc. to provide healthcare solutions for chronic health conditions. The company announced to offer Spinal Cord Stimulator (SCS) systems and Deep Brain Stimulation (DBS) systems for the treatment of patients suffering from Parkinson's disease and Dystonia.
On the other hand, glucose monitoring, air flow monitoring and connected pharmaceuticals expected to be the fastest growing market in upcoming years leading to the manufacturing pace of AstraZeneca, Dexcom, Merck, Novartis, Propeller Health, Proteus Digital Health, Roche, Sanofi, Voluntis and WellDoc.
Market Segmentation
The global remote patient monitoring solutions market is segmented on the following basis:
• Based on Services
o Telemedicine
o Telecare
o Telehealth
o Other (eHealth, Digital Health)
• Based on Application
o Cancer Treatment
o Diabetes Treatment
o Fitness and Wellness Monitoring
o Cardiovascular Disease Treatment
• Based on End-User
o Hospitals
o Home Healthcare
o Clinics
o Others (Ambulatory Services)
• Based on Geography
o North America (U.S. & Canada) {Market Size (USD Billion), Market Share (%)}
o Latin America (Brazil, Mexico & Rest of Latin America){Market Size (USD Billion), Market Share (%)}
o Europe (The U.K., Germany, France, Italy, Spain, Russia, Poland, Sweden & RoE) {Market Size (USD Billion), Market Share (%)}
o Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand andRest of Asia) {Market Size (USD Billion), Market Share (%)}
o Middle East & Africa (GCC, South Africa, North Africa andRoMEA) {Market Size (USD Billion), Market Share (%)}
o Rest of World {Market Size (USD Billion), Market Share (%)}
Market Size and Forecast (2016-2024)
Self-management and personalized health care at home is raising the adoption rate of remote patient monitoring solutions among elderly population. Continuous monitoring and real time diagnostics solutions are enhancing the healthcare quality. According to our research, implementation of remote patient monitoring solutions has potential to reduce the hospital admission rate by 60%. The global remote patient monitoring solutions market is anticipated to reach USD 48.5 billion by 2024 from USD 17.0 billion in 2016, growing at a CAGR of 14% during the forecast period. Based on end-user segment, hospitals are projected to account for over 47% revenue share in global remote patient monitoring device market by 2024. However, home healthcare segment is expected to occupy 25% market share by the end of 2024. Cardiovascular disease treatment application segment generated a revenue share of 22% of remote patient monitoring solution market in 2016. Moreover, diabetes treatment application is anticipated to occupy 17% revenue share in global remote patient monitoring solutions market by the end of 2024.
In 2014, Europe and North America together occupied 75% share of global remote patient monitoring solutions market. Rising number of chronic diseases and rapid adoption rate of innovative healthcare solutions are driving the demand for remote patient monitoring devices in Europe and North America region. Government initiatives and reimbursement policies which are improving the health awareness among population is likely to drive the remote patient monitoring solutions market during the forecast period. North America is the dominating region in remote patient monitoring solutions market followed by Europe. North America accounted for 35% share of total remote patient monitoring solutions market in 2016 and is expected to dominate over the forecast period of 2016 to 2024. However, huge investment in digital health strategies, reimbursement policies and rising adoption of health apps and fitness trackers are driving the Europe remote patient monitoring solutions market. In 2014, National Health Services (NHS), England invested in deployment of digital strategies in healthcare industry. Europe remote patient monitoring solutions market is expected to reach USD 14.5 billion by 2024, growing at a CAGR of 12.0% over the forecast period.
Increase in ageing population and rising health awareness are the two major drivers for the growth of Asia-Pacific remote patient monitoring solutions market. Countries such as China, Japan, Singapore, Australia and India are investing to enhance their healthcare infrastructures. This is likely to accelerate the remote patient monitoring solutions market in the region. Asia-Pacific remote patient monitoring solutions market valued USD 4.7 billion in 2016 and is projected to reach approximately USD 13.5 billion by 2024, expanding at a CAGR of around 13.0% during time period of 2016 to 2024.
Lack of proper interaction with advanced technology and lack of healthcare infrastructure is limiting the growth of remote patient monitoring solutions in Latin America and Middle East & Africa region. However, government initiatives towards creating awareness about proper sanitation and investment to improve medical facilities are likely to raise the demand for remote patient monitoring solutions in the region. Latin America and Middle East & Africa region together expected to occupy 7% of the total market share by 2024.
Market Drivers and Challenges
Rising frequency of chronic health issues mainly cardiovascular diseases, diabetes and respiratory problems is driving the adoption rate of remote patient monitoring solutions around the world. Growing health awareness and independent living among people is boosting the demand of remote patient monitoring devices. Government investment in improving healthcare facilities and effective treatment is impelling the demand of remote patient monitoring solutions across the globe. Technological advancement in treatment facilities and internet of things (IoT) based connected devices is spurring the growth of remote patient monitoring solutions market globally.
Lack of trained medical professionals to assist with remote monitoring devices for patients is expected to restrain the adoption rate of remote patient monitoring solutions. High cost of remote patient monitoring systems and patient privacy concern are majorly hindering the growth of remote patient monitoring solutions. Lack of awareness about remote patient monitoring devices and lack of appropriate reimbursement policies are some of the challenges which are obstructing the expansion of remote patient monitoring solutions market across the globe.
Key Market Players
• GE Healthcare Ltd.
o Synopsis
o Business Strategy
o Product Portfolio
o SWOT Analysis
• Abbott Laboratories
• Aerotel Medical Systems
• Medtronic Plc
• Johnson & Johnson
• Honeywell Life care Solutions
• Biotronik
• Philips Healthcare
• Boston Scientific
Scope Background
Market Synopsis
Market Segmentation
The Global Remote Patient Monitoring Solutions is segmented as follows:
• By Services Type (Market Size, Demand Analysis and Growth Analysis)
• By Application Type (Market Size, Demand Analysis and Growth Analysis)
• By End-User Type (Market Size, Demand Analysis and Growth Analysis)
By Regions
• North America (U.S., Canada) {Market Size, Growth Analysis and Opportunity Analysis}
• Latin America (Argentina, Mexico, Brazil and Rest of Latin America) {Market Size, Growth Analysis and Opportunity Analysis}
• Europe (Germany, Italy, Spain, France, The U.K., Netherlands, Sweden, Hungary, Russia, Poland, Rest of Europe) {Market Size, Growth Analysis and Opportunity Analysis}
• Asia-Pacific (China, India, Singapore, Japan, Hong-Kong, Australia, New Zealand, South Korea and Rest of Asia Pacific) {Market Size, Growth Analysis and Opportunity Analysis}
• Middle East and North Africa (MENA) {Market Size, Growth Analysis and Opportunity Analysis}
• Rest of World {Market Size, Growth Analysis and Opportunity Analysis}
Market Dynamics: Growth Drivers, Restraints and Opportunities
• Risk Factors
• Regional Variations
• Recent Trends and Developments
Key Market Players
• Synopsis
• Business Strategy
• Product Portfolio
• SWOT Analysis
Porter’s Five Force Model
Market Landscape: Competition and Beyond
Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
Expert Analysis
Concluding Remark

Table of Contents
1. Parent Market Synopsis
2. Executive Summary
3. Research Methodology
4. Regional Opportunity Analysis on the basis of Competitors
5. Global Remote Patient Monitoring Solutions Market Size (USD Billion) and Forecast Analysis, 2016-2024
6. Market Dynamics: Growth Drivers, Restraints and Opportunities
6.1. Risk Factors
6.2. Regional Variations
6.3. Recent Trends and Developments
7. Global Remote Patient Monitoring Solutions Market Segmentation
7.1. By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.1. Adoption Rate (%) by Services
7.1.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.1.6. Market Attractiveness by Services
7.1.7. BPS Analysis by Services
7.2. By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.1. Adoption Rate (%) by Application
7.2.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.2.7. BPS Analysis by Application
7.3. By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.1. Adoption Rate (%) by End Users
7.3.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.3.6. Market Attractiveness by End Users
7.3.7. BPS Analysis by End Users
7.4. By Region (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.1. North America Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.1. North America By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.1.1.1. U.S. Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.1.2. Canada (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.1.3. Market Attractiveness by Country
7.4.1.1.4. BPS Analysis by Country
7.4.1.2. North America By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.2.1. Adoption Rate (%) by Services
7.4.1.2.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.2.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.2.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.2.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.2.6. Market Attractiveness by Services
7.4.1.2.7. BPS Analysis by Services
7.4.1.3. North America By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.1. Adoption Rate (%) by Application
7.4.1.3.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.3.7. BPS Analysis by Application
7.4.1.4. North America By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.4.1. Adoption Rate (%) by End Users
7.4.1.4.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.4.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.4.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.1.4.6. Market Attractiveness by End Users
7.4.1.4.7. BPS Analysis by End Users
7.4.2. Europe Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1. Europe By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.2.1.1. UK Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.2. France (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.3. Italy (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.4. Germany (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.5. Spain (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.6. Hungary (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.7. Sweden (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.8. Russia (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.9. Poland (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.10. Rest of Europe (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.1.11. Market Attractiveness by Country
7.4.2.1.12. BPS Analysis by Country
7.4.2.2. Europe By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.2.1. Adoption Rate (%) by Services
7.4.2.2.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.2.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.2.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.2.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.2.6. Market Attractiveness by Services
7.4.2.2.7. BPS Analysis by Services
7.4.2.3. Europe By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.1. Adoption Rate (%) by Application
7.4.2.3.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.3.7. BPS Analysis by Application
7.4.2.4. Europe By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.4.1. Adoption Rate (%) by End Users
7.4.2.4.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.4.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.4.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.2.4.6. Market Attractiveness by End Users
7.4.2.4.7. BPS Analysis by End Users
7.4.3. Middle East & Africa Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.1. Middle East & Africa By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.3.1.1. Gulf Cooperation Council Countries (GCC) Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.1.2. South Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.1.3. North Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.1.4. Rest of Middle East and Africa (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.1.5. Market Attractiveness by Country
7.4.3.1.6. BPS Analysis by Country
7.4.3.2. Middle East & Africa By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.2.1. Adoption Rate (%) by Services
7.4.3.2.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.2.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.2.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.2.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.2.6. Market Attractiveness by Services
7.4.3.2.7. BPS Analysis by Services
7.4.3.3. Middle East & Africa By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.1. Adoption Rate (%) by Application
7.4.3.3.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.3.7. BPS Analysis by Application
7.4.3.4. Middle East & Africa By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.4.1. Adoption Rate (%) by End Users
7.4.3.4.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.4.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.4.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.3.4.6. Market Attractiveness by End Users
7.4.3.4.7. BPS Analysis by End Users
7.4.4. Latin America Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.1. Latin America By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.4.1.1. Brazil Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.1.2. Mexico (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.1.3. Rest of Latin America (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.1.4. Market Attractiveness by Country
7.4.4.1.5. BPS Analysis by Country
7.4.4.2. Latin America By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.2.1. Adoption Rate (%) by Services
7.4.4.2.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.2.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.2.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.2.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.2.6. Market Attractiveness by Services
7.4.4.2.7. BPS Analysis by Services
7.4.4.3. Latin America By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.1. Adoption Rate (%) by Application
7.4.4.3.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.3.7. BPS Analysis by Application
7.4.4.4. Latin America By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.4.1. Adoption Rate (%) by End Users
7.4.4.4.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.4.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.4.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.4.4.6. Market Attractiveness by End Users
7.4.4.4.7. BPS Analysis by End Users
7.4.5. Asia Pacific (APAC) Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1. Asia Pacific By Country (Market Share (%) & Y-o-Y Growth Comparison, 2016-2024)
7.4.5.1.1. China Market (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.2. Japan (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.3. India (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.4. Singapore (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.5. South Korea (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.6. Australia (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.7. New Zealand (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.8. Rest of APAC (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.1.9. Market Attractiveness by Country
7.4.5.1.10. BPS Analysis by Country
7.4.5.2. Asia Pacific By Services (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.2.1. Adoption Rate (%) by Services
7.4.5.2.2. Telemedicine (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.2.3. Telecare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.2.4. Telehealth (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.2.5. Other (eHealth, Digital Health) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.2.6. Market Attractiveness by Services
7.4.5.2.7. BPS Analysis by Services
7.4.5.3. Asia Pacific By Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.1. Adoption Rate (%) by Application
7.4.5.3.2. Cancer Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.3. Diabetes Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.4. Fitness and Wellness Monitoring (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.5. Cardiovascular Disease Treatment (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.6. Market Attractiveness by Application (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.3.7. BPS Analysis by Application
7.4.5.4. Asia Pacific By End Users (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.4.1. Adoption Rate (%) by End Users
7.4.5.4.2. Hospitals (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.4.3. Home Healthcare (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.4.4. Clinics (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.4.5. Others (Ambulatory Services) (Market Size ($ Billion) & Y-o-Y Growth Analysis, 2016-2024)
7.4.5.4.6. Market Attractiveness by End Users
7.4.5.4.7. BPS Analysis by End Users
8. Competitive Outlook
8.1. Market Share of Major Players (2016)
8.2. Company Profiles
8.2.1. GE Healthcare Ltd.
8.2.1.1. Company Synopsis
8.2.1.2. Business Strategy
8.2.1.3. Product Portfolio
8.2.1.4. SWOT Analysis
8.2.2. Abbott Laboratories
8.2.3. Aerotel Medical Systems
8.2.4. Medtronic Plc
8.2.5. Johnson & Johnson
8.2.6. Honeywell Life care Solutions
8.2.7. Biotronik
8.2.8. Philips Healthcare
8.2.9. Boston Scientific
9. PorterΒ’s Five Force Model
10. Market Landscape: Competition and Beyond
11. Market outlook for business players and entry level players to ascertain their business in dynamic ecosystem
12. Expert Analysis
13. Concluding Remarks

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $4750
USD $5500
USD $6000
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.